GPI-anchoring disorders and the heart: Is cardiomyopathy an overlooked feature?

Allan Bayat*, Tobias Lindau, Angel Aledo-Serrano, Antonio Gil-Nagel, Ivo Barić, Dorotea Bartoniček, Josipa Mateševac, Danijela Petković Ramadža, Tamara Žigman, Silvija Pušeljić, Sanja Dorner, Caleb Bupp, Seth Devries, Rikke Steensbjerre Møller

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

20 Downloads (Pure)

Abstract

Glycosylphosphatidylinositol anchoring disorders (GPI-ADs) are a subgroup of congenital disorders of glycosylation. GPI biosynthesis requires proteins encoded by over 30 genes of which 24 genes are linked to neurodevelopmental disorders. Patients, especially those with PIGA-encephalopathy, have a high risk of premature mortality which sometimes is attributed to cardiomyopathy. We aimed to explore the occurrence of cardiomyopathy among patients with GPI-ADs and to raise awareness about this potentially lethal feature. Unpublished patients with genetically proven GPI-ADs and cardiomyopathy were identified through an international collaboration and recruited through the respective clinicians. We also reviewed the literature for published patients with cardiomyopathy and GPI-AD and contacted the corresponding authors for additional information. We identified four novel and unrelated patients with GPI-AD and cardiomyopathy. Cardiomyopathy was diagnosed before adulthood and was the cause of early demise in two patients. Only one patients underwent cardiac workup after being diagnosed with a GPI-AD. All were diagnosed with PIGA-encephalopathy and three had a disease-causing variant at the same residue. The literature reports five additional children with GPI-AD related cardiomyopathy, three of which died before adulthood. We have shown that patients with GPI-ADs are at risk of developing cardiomyopathy and that regular cardiac workup with echocardiography is necessary.

Original languageEnglish
JournalClinical Genetics
Volume104
Issue number5
Pages (from-to)598-603
ISSN0009-9163
DOIs
Publication statusPublished - Nov 2023

Bibliographical note

Publisher Copyright:
© 2023 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.

Keywords

  • cardiomyopathy
  • genetics
  • glycosylphosphatidylinositol biosynthesis defects
  • GPI
  • GPIAD
  • heart
  • mortality
  • PIGA
  • Humans
  • Adult
  • Brain Diseases
  • Cardiomyopathies/diagnosis
  • Glycosylphosphatidylinositols/genetics
  • Child

Fingerprint

Dive into the research topics of 'GPI-anchoring disorders and the heart: Is cardiomyopathy an overlooked feature?'. Together they form a unique fingerprint.

Cite this